Lung cancers can use two different mechanisms to evade KRAS-inhibiting drugs

Some tumor cells develop resistance by amplifying the KRAS gene, while others change their tumor type, MIT researchers have found.

By TraftonSep 30, 2026

Score████░░░░░░3.7

VerdictCompetent work. Briefs at most.

Summary from the source

Some tumor cells develop resistance by amplifying the KRAS gene, while others change their tumor type, MIT researchers have found.

Anne Trafton

Heuristic review

Dimension	Level	Weight	What that level means
Leverage	██░░░ 2	15%	Reusable within one subfield (a technique, dataset, or protocol a few groups will adopt).
Magnitude	██░░░ 2	20%	Solid incremental gain on a meaningful problem.
Evidence	██░░░ 2	20%	Limited: single setting, weak baselines, or an observational association presented as causal.
Novelty	██░░░ 2	10%	A new combination of known ideas.
Trajectory	██░░░ 2	10%	Some room to improve with obvious engineering.
Stakes	██░░░ 2	25%	Benefits a professional community (practitioners, clinicians, engineers).

Editor’s rationale

Heuristic triage from title and abstract text only, not a reading of the paper. No strong cues found.

rank-2026-09-29

Score████░░░░░░3.7

Score = 10 × (50% × adjusted merit / 10 + 25% × attention + 25% × freshness)

Merit: 3.4 / 10; Weighted rubric, evidence-gated.
Adjusted merit: 3.8 / 10; Shrunk toward the desk prior by editor confidence (30%).
Attention: 24%; Citations, upvotes, points, mentions.
Freshness: 49%; Half-life decay since publication.

No attention signals recorded yet.

Reviewed by heuristic-v2 on Sep 30, 2026, 11:05 UTC. Paper type: news.
Categories: Research, Genetics, Cancer, Biology, Koch Institute, School of Science, National Institutes of Health (NIH)
BRIEF, No.1 in the News edition of September 30, 2026.